Literature DB >> 17936243

Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells.

Kenji Kuwayama1, Hiroyuki Inoue, Tatsuyuki Kanamori, Kenji Tsujikawa, Hajime Miyaguchi, Yuko Iwata, Seiji Miyauchi, Naoki Kamo, Tohru Kishi.   

Abstract

3,4-methylenedioxymethamphetamine (MDMA) is an illegal amphetamine-type stimulant (ATS) that is abused orally in the form of tablets for recreational purposes. The aim of this work is to investigate the absorption mechanism of MDMA and other related compounds that often occur together in ATS tablets, and to determine whether such tablet components interact with each other in intestinal absorption. The characteristics of MDMA uptake by the human intestinal epithelial Caco-2 cell line were investigated. The Michaelis constant and the maximal uptake velocity at pH 6.0 were 1.11 mM and 13.79 nmol/min/mg protein, respectively, and the transport was electroneutral. The initial uptake rate was regulated by both intra- and extracellular pH. MDMA permeation from the apical to the basolateral side was inferior to that in the reverse direction, and a decrease in apical pH enhanced MDMA permeation from the basolateral to the apical side. These facts indicate that this transport system may be an antiporter of H+. However, under physiological conditions, the proton gradient cannot drive the MDMA uptake because it is inwardly directed. Large concentration differences of MDMA itself drive this antiporter. Various compounds with similar amine moieties inhibited the uptake, but substrates of organic cation transporters (OCT1-3) and an H+-coupled efflux antiporter, MATE, were not recognized.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936243     DOI: 10.1016/j.bbamem.2007.08.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.

Authors:  Hélène Chapy; Pascal André; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

Review 2.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

3.  Diphenhydramine as a selective probe to study H+-antiporter function at the blood-brain barrier: Application to [11C]diphenhydramine positron emission tomography imaging.

Authors:  Sylvain Auvity; Hélène Chapy; Sébastien Goutal; Fabien Caillé; Benoit Hosten; Maria Smirnova; Xavier Declèves; Nicolas Tournier; Salvatore Cisternino
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Hélène Chapy; Pascal André; Maria Smirnova; Marcel Debray; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2012-12-05       Impact factor: 4.009

5.  Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.

Authors:  Hélène Chapy; Laura Goracci; Philippe Vayer; Yannick Parmentier; Pierre-Alain Carrupt; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino; Gabriele Cruciani
Journal:  Br J Pharmacol       Date:  2015-10-13       Impact factor: 8.739

6.  Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.

Authors:  Hélène Chapy; Maria Smirnova; Pascal André; Joël Schlatter; Fouad Chiadmi; Pierre-Olivier Couraud; Jean-Michel Scherrmann; Xavier Declèves; Salvatore Cisternino
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

7.  Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line.

Authors:  Maria Smirnova; Laura Goracci; Gabriele Cruciani; Laetitia Federici; Xavier Declèves; Hélène Chapy; Salvatore Cisternino
Journal:  Pharmaceutics       Date:  2022-01-21       Impact factor: 6.321

8.  Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.

Authors:  Keita Shimomura; Takashi Okura; Sayaka Kato; Pierre-Olivier Couraud; Jean-Michel Schermann; Tetsuya Terasaki; Yoshiharu Deguchi
Journal:  Fluids Barriers CNS       Date:  2013-01-26

Review 9.  Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?

Authors:  Christoph Wenzel; Marek Drozdzik; Stefan Oswald
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.